Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Queensland Health
Cipla
Colorcon
Novartis
Mallinckrodt
McKesson
Accenture
Johnson and Johnson

Generated: February 21, 2018

DrugPatentWatch Database Preview

Disulfiram - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for disulfiram and what is the scope of disulfiram patent protection?

Disulfiram
is the generic ingredient in two branded drugs marketed by Odyssey Pharms, Teva Womens, Chartwell Molecules, Mylan Pharms Inc, Par Pharm, Sigmapharm Labs Llc, Watson Labs, Watson Labs Teva, West-ward Pharms Int, and Alvogen Malta, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for disulfiram. Ten suppliers are listed for this compound.
Pharmacology for disulfiram
Medical Subject Heading (MeSH) Categories for disulfiram

US Patents and Regulatory Information for disulfiram

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int DISULFIRAM disulfiram TABLET;ORAL 202652-002 Feb 5, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Womens ANTABUSE disulfiram TABLET;ORAL 007883-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs Teva DISULFIRAM disulfiram TABLET;ORAL 086890-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Womens ANTABUSE disulfiram TABLET;ORAL 007883-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Chartwell Molecules DISULFIRAM disulfiram TABLET;ORAL 091563-002 Dec 31, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc DISULFIRAM disulfiram TABLET;ORAL 203916-001 Mar 4, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Odyssey Pharms ANTABUSE disulfiram TABLET;ORAL 088483-001 Dec 8, 1983 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Chartwell Molecules DISULFIRAM disulfiram TABLET;ORAL 091563-001 Dec 31, 2012 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Pharm DISULFIRAM disulfiram TABLET;ORAL 088793-001 Aug 14, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Pharm DISULFIRAM disulfiram TABLET;ORAL 088792-001 Aug 14, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Dow
Daiichi Sankyo
Cerilliant
Covington
Farmers Insurance
Cipla
Queensland Health
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot